Michael Edmund Beck (Michael E Beck)

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Molecular Dynamics Simulations

Capillary Electrophoresis

Protein Protein

Advanced Non Small Cell Lung Cancer

Top Venues

ACS medicinal chemistry letters

Science advances

Journal of computer-aided molecular design

Journal of computational chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, Tom Schulz, Sandra Koska, Silke Kleinbölting, Michael Edmund Beck, Matthias Philipp Müller, Daniel Rauh
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines. ACS medicinal chemistry letters 14 (5) (2023)
Matthias Koch, Oliver Schaudt, Georg Mogk, Thomas Mrziglod, Helmut Berg, Michael Edmund Beck
A Variational Ansatz for Taylorized Imaginary Time Evolution. ACS omega 8 (25) (2023)
Julian Haas, Elena Beck, Bartlomiej J Troczka, Angela Hayward, Gillian Hertlein, Marion Zaworra, Bettina Lueke, Benjamin Buer, Frank Maiwald, Michael Edmund Beck, Birgit Nebelsiek, Johannes Glaubitz, Chris Bass, Ralf Nauen
A conserved hymenopteran-specific family of cytochrome P450s protects bee pollinators from toxic nectar alkaloids. Science advances 9 (15) (2023)
Tobias Grabe, Kirujan Jeyakumar, Janina Niggenaber, Tom Schulz, Sandra Koska, Silke Kleinbölting, Michael Edmund Beck, Matthias Philipp Müller, Daniel Rauh
Addressing the Osimertinib Resistance Mutation EGFR-L858R/C797S with Reversible Aminopyrimidines. ACS medicinal chemistry letters 14 (5) (2023)
Michael Edmund Beck, Christoph Riplinger, Frank Neese, Giovanni Bistoni
Unraveling individual host-guest interactions in molecular recognition from first principles quantum mechanics: Insights into the nature of nicotinic acetylcholine receptor agonist binding. Journal of computational chemistry 42 (5) (2020)
Michael Edmund Beck, Jacopo Negroni, Svend Matthiesen, Michael Kohnen, Christoph Riplinger
A binding mode hypothesis for prothioconazole binding to CYP51 derived from first principles quantum chemistry. Journal of computer-aided molecular design 35 (4) (2020)